organization · Reporting owner
BXHCP SP III, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SERA PROGNOSTICS, INC.
Report date July 18, 2022 · Filed July 19, 2022
Jointly reported with Blue Ox Healthcare Partners, LLC, Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC
Section 16 reporting ended · disclosed 2022-07-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Blue Ox Healthcare Partners SP, LLC | 132,501 |
Reported balance
After 2022-07-18 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2022-07-18 · Other · Disposed 1,383,094 · Balance 132,501 F1: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements. F2: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy BXHCP SP II, LLC | 77,420 |
Reported balance
After 2022-07-18 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2022-07-18 · Other · Disposed 997,627 · Balance 77,420 F1: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements. F2: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy BXHCP SP III, LLC | 46,744 |
Reported balance
After 2022-07-18 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2022-07-18 · Other · Disposed 1,157,764 · Balance 46,744 F1: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements. F2: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements.
F2: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2022 Filed Jul 19, 2022 17:20 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | OtherClass A Common Stock | 1,157,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014188 · doc1.xml · nonDerivative · entry 3 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By BXHCP SP III, LLC Disclosed balance after: 46,744 F1 · kind: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements. F2 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 17:20 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | OtherClass A Common Stock | 997,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014188 · doc1.xml · nonDerivative · entry 2 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By BXHCP SP II, LLC Disclosed balance after: 77,420 F1 · kind: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements. F2 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 17:20 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | OtherClass A Common Stock | 1,383,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014188 · doc1.xml · nonDerivative · entry 1 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Blue Ox Healthcare Partners SP, LLC Disclosed balance after: 132,501 F1 · kind: Shares have been distributed pro rata for no consideration to certain members of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC in accordance with the required distribution of marketable securities stipulation in the respective Limited Liability Company Agreements. F2 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 17:07 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries E Convertible Preferred Stock · Derivative | 1,204,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094475 · tm2122872-2_4seq1.xml · derivative · entry 6 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By BXHCP SP III, LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 1,204,508 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents shares of Series E Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F2 · price: Represents shares of Series E Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F2 · derivative.exercise_date: Represents shares of Series E Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F2 · derivative.expiration_date: Represents shares of Series E Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 17:07 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries D Convertible Preferred Stock · Derivative | 1,075,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094475 · tm2122872-2_4seq1.xml · derivative · entry 5 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By BXHCP SP II, LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 1,075,047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F1 · price: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 17:07 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionSeries D Convertible Preferred Stock · Derivative | 1,515,595 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094475 · tm2122872-2_4seq1.xml · derivative · entry 4 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Blue Ox Healthcare Partners SP, LLC Disclosed balance after: 0 Underlying: Class A Common Stock · 1,515,595 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F1 · price: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 17:07 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 1,204,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094475 · tm2122872-2_4seq1.xml · nonDerivative · entry 3 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By BXHCP SP III, LLC Disclosed balance after: 1,204,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents shares of Series E Convertible Preferred Stock were automatically converted into Common Stock in connection with the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 17:07 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 1,075,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094475 · tm2122872-2_4seq1.xml · nonDerivative · entry 2 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By BXHCP SP II, LLC Disclosed balance after: 1,075,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 17:07 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | ConversionClass A Common Stock | 1,515,595 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094475 · tm2122872-2_4seq1.xml · nonDerivative · entry 1 Blue Ox Healthcare Partners, LLC · CIK 0001873840 · 10% owner Blue Ox Healthcare Partners SP, LLC · CIK 0001785138 · 10% owner BXHCP SP II, LLC · CIK 0001804589 · 10% owner BXHCP SP III, LLC · CIK 0001862000 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Blue Ox Healthcare Partners SP, LLC Disclosed balance after: 1,515,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of Series D Convertible Preferred Stock were automatically converted into Class A Common Stock in connection with the closing of the Issuer's initial public offering. The Series D Convertible Preferred Stock had no expiration date. F3 · ownership.nature: Blue Ox Healthcare Partners, LLC is the manager of each of Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC, and may be deemed to have voting, investment and dispositive power with respect to the shares held by Blue Ox Healthcare Partners SP, LLC, BXHCP SP II, LLC, and BXHCP SP III, LLC. Charles D. Kennedy MD, Oded Levy, and John A. Neczesny, managing partners of Blue Ox Healthcare Partners, LLC, each may be deemed to share voting, investment and dispositive power with respect to these shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.